Watchful waiting and quality of life among prostate cancer survivors in the physicians' health study

Journal of Urology

Volumn 186, Issue 5, 2011, Pages 1862-1867

  Kasperzyk, Julie L ^a,b   Shappley III, William V ^d   Kenfield, Stacey A ^a,b   Mucci, Lorelei A ^a,b   Kurth, Tobias ^a,b,e   Ma, Jing ^b   Stampfer, Meir J ^a,b   Sanda, Martin G ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

mortality; outcome and process assessment (health care); prostate; prostatic neoplasms; quality of life

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; COMORBIDITY; DIARRHEA; EARLY CANCER; GLEASON SCORE; HEMATURIA; HORMONAL THERAPY; HOT FLUSH; HUMAN; IMPOTENCE; INFORMATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; THERAPY DELAY; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE; VOMITING; WATCHFUL WAITING; AGE; BODY MASS; CANCER GRADING; CONTROLLED STUDY; ERECTILE DYSFUNCTION; INCIDENTAL FINDING; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; URINARY INCONTINENCE;

AGE FACTORS; AGED; BODY MASS INDEX; COMORBIDITY; ERECTILE DYSFUNCTION; HUMANS; INCIDENTAL FINDINGS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; URINARY INCONTINENCE; WATCHFUL WAITING;

EID: 80053972731     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.06.058     Document Type: Article

References (30)

1. A. Jemal, R. Siegel, and J. Xu Cancer Statistics, 2010 CA Cancer J Clin 60 2010 277
2. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
3. J. Hugosson, S. Carlsson, and G. Aus Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2010 725
4. C. Warlick, B.J. Trock, and P. Landis Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355
5. L. Klotz Active surveillance for favorable-risk prostate cancer: who, how and why? Nat Clin Pract Oncol 4 2007 692
6. M.A. Dall'Era, M.R. Cooperberg, and J.M. Chan Active surveillance for early-stage prostate cancer: review of the current literature Cancer 112 2008 1650
7. M.I. Patel, D.T. DeConcini, and E. Lopez-Corona An analysis of men with clinically localized prostate cancer who deferred definitive therapy J Urol 171 2004 1520
8. W.V. Shappley 3rd, S.A. Kenfield, and J.L. Kasperzyk Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort J Clin Oncol 27 2009 4980
9. T.M. Koppie, G.D. Grossfeld, and D. Miller Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from the CaPSURE database Cancer of the Prostate Strategic Urological Research Endeavor J Urol 164 2000 81
10. A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 2005 1977
11. G. Steineck, F. Helgesen, and J. Adolfsson Quality of life after radical prostatectomy or watchful waiting N Engl J Med 347 2002 790
12. S.A. Arredondo, T.M. Downs, and D.P. Lubeck Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE J Urol 172 2004 1830
13. G. Katz, and R. Rodriguez Changes in continence and health-related quality of life after curative treatment and watchful waiting of prostate cancer Urology 69 2007 1157
14. M.S. Litwin, R.D. Hays, and A. Fink Quality-of-life outcomes in men treated for localized prostate cancer JAMA 273 1995 129
15. M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250
16. C.H. Hennekens, and K. Eberlein A randomized trial of aspirin and beta-carotene among U.S. physicians Prev Med 14 1985 165
17. H.D. Sesso, J.E. Buring, and W.G. Christen Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial JAMA 300 2008 2123
18. Final report on the aspirin component of the ongoing Physicians' Health Study Steering Committee of the Physicians' Health Study Research Group N Engl J Med 321 1989 129
19. C.H. Hennekens, J.E. Buring, and J.E. Manson Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1996 1145
20. D.P. Lubeck, M.S. Litwin, and J.M. Henning Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE Urology 53 1999 180
21. M.S. Litwin, R.D. Hays, and A. Fink The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002
22. M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373
23. J.A. Driver, T. Kurth, and J.E. Buring Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study Neurology 70 2008 1423
24. S. Loeb, and W.J. Catalona Prostate-specific antigen in clinical practice Cancer Lett 249 2007 30
25. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
26. F. Fang, J.L. Kasperzyk, and I. Shui Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer PLoS One 6 2011 e18625
27. W.K. Hendrickson, R. Flavin, and J.L. Kasperzyk Vitamin D receptor protein expression in tumor tissue and prostate cancer progression J Clin Oncol 29 2011 2378
28. M.V. Meng, E.P. Elkin, and S.R. Harlan Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE J Urol 170 2003 2279
29. H. Wu, L. Sun, and J.W. Moul Watchful waiting and factors predictive of secondary treatment of localized prostate cancer J Urol 171 2004 1111
30. M.M. Schapira, W.F. Lawrence, and D.A. Katz Effect of treatment on quality of life among men with clinically localized prostate cancer Med Care 39 2001 243